New combo therapy trial aims to tame aggressive breast cancer
NCT ID NCT01898117
Summary
This study is for people with advanced triple-negative breast cancer, a hard-to-treat type. It tests if adding an immunotherapy drug (atezolizumab) to standard first-line chemotherapy helps control the cancer better and for longer. Researchers also want to learn which patients are most likely to benefit from this combination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZVU
Amsterdam, 1081 HV, Netherlands
-
Admiraal de Ruyter ziekenhuis
Goes, Netherlands
-
Albert Schweitzer Ziekenhuis
Dordrecht, Netherlands
-
Amphia
Breda, Netherlands
-
BovenIJ
Amsterdam, 1034 CS, Netherlands
-
Bravis ziekenhuis
Roosendaal, Netherlands
-
Catharina ziekenhuis
Eindhoven, Netherlands
-
Deventer ziekenhuis
Deventer, 7416 SE, Netherlands
-
Diakonessenziekenhuis
Utrecht, Netherlands
-
Dijklander ziekenhuis
Hoorn, Netherlands
-
Elisabeth Tweesteden ziekenhuis
Tilburg, 5042 AD, Netherlands
-
Gelre Ziekenhuis
Apeldoorn, Netherlands
-
Groene Hart
Gouda, 2803 HH, Netherlands
-
Groene Hart Ziekenhuis
Gouda, Netherlands
-
Haaglanden MC
Leidschendam, 2262 BA, Netherlands
-
Haga
The Hague, 2545 CH, Netherlands
-
IJsselland ziekenhuis
Capelle aan den IJssel, 2906 ZC, Netherlands
-
Ikazia
Rotterdam, 3083 AN, Netherlands
-
Isala Klinieken
Zwolle, 8025 AB, Netherlands
-
Jeroen Bosch ziekenhuis
Eindhoven, Netherlands
-
LUMC
Leiden, 2333 ZA, Netherlands
-
Lievensberg ziekenhuis
Bergen op Zoom, 4624 VT, Netherlands
-
MCA
Alkmaar, 1815 JD, Netherlands
-
MCL
Leeuwarden, 8934 AD, Netherlands
-
MUMC
Maastricht, Netherlands
-
Maasstad Ziekenhuis
Rotterdam, Netherlands
-
Martini Ziekenhuis
Groningen, Netherlands
-
Maxima Medisch Centrum
Eindhoven, 5631 BM, Netherlands
-
Meander Medisch Centrum
Amersfoort, Netherlands
-
Medisch Spectrum Twente (MST)
Enschede, Netherlands
-
Netherlands Cancer Institute
Amsterdam, 1066 CX, Netherlands
-
Nijsmellinghe
Drachten, 9202 NN, Netherlands
-
Noordwest Ziekenhuis Groep
Alkmaar, Netherlands
-
OLVG
Amsterdam, Netherlands
-
Reinier de Graaf Gasthuis
Delft, Netherlands
-
Rijnstate
Arnhem, Netherlands
-
Rode Kruis Ziekenhuis
Beverwijk, 1940 EB, Netherlands
-
Spaarne Gasthuis
Hoofddorp, 2134 TM, Netherlands
-
St. Antonius ziekenhuis
Nieuwegein, Netherlands
-
St. Fransicus Gasthuis
Rotterdam, 3045 PM, Netherlands
-
St. Jansdal
Harderwijk, Netherlands
-
Stichting Franciscus Vlietland Groep locatie Gasthuis
Rotterdam, Netherlands
-
Tergooi ziekenhuizen
Hilversum, Netherlands
-
UMCU
Utrecht, Netherlands
-
VieCuri Medisch Centrum voor Noord-Limburg
Venlo, Netherlands
-
Vlietland ziekenhuis
Schiedam, 3118 JH, Netherlands
-
ZGT
Almelo, 7609 PP, Netherlands
-
Ziekenhuis Gelderse Vallei
Ede, 6716 RP, Netherlands
-
Zuyderland
Sittard, Netherlands
Conditions
Explore the condition pages connected to this study.